Eris Lifesciences Limited (BOM:540596)
India · Delayed Price · Currency is INR 1,176.20
-21.30 (-1.78%)
At close: Oct 28, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 163.07 billion as of October 28, 2026. Its market cap has decreased by 26.45% in one year.
Market Cap
163.07B
Enterprise Value
184.80B
Revenue
33.15B
Global Rank
n/a
Country Rank
n/a
PE Ratio
22.94
ChartMarket Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 163.07B, an increase of 97.17%. That is a compound annual growth rate of 7.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 163.07B | -20.49% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 306.27B |
| Piramal Pharma | 264.15B |
| Cohance Lifesciences | 183.36B |
| Eris Lifesciences | 166.26B |
| Alivus Life Sciences | 164.96B |
| NATCO Pharma | 155.87B |
| Alembic Pharmaceuticals | 150.74B |
| Sudeep Pharma | 115.48B |